KR20240165977A - 의약 제제의 멸균법과 포장체 - Google Patents

의약 제제의 멸균법과 포장체 Download PDF

Info

Publication number
KR20240165977A
KR20240165977A KR1020247034479A KR20247034479A KR20240165977A KR 20240165977 A KR20240165977 A KR 20240165977A KR 1020247034479 A KR1020247034479 A KR 1020247034479A KR 20247034479 A KR20247034479 A KR 20247034479A KR 20240165977 A KR20240165977 A KR 20240165977A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
salt
aqueous pharmaceutical
pyrido
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247034479A
Other languages
English (en)
Korean (ko)
Inventor
요코 엔도
겐지 마사키
구미 셈바
Original Assignee
산텐 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 산텐 세이야꾸 가부시키가이샤 filed Critical 산텐 세이야꾸 가부시키가이샤
Publication of KR20240165977A publication Critical patent/KR20240165977A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hematology (AREA)
KR1020247034479A 2022-03-30 2023-03-29 의약 제제의 멸균법과 포장체 Pending KR20240165977A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022056765 2022-03-30
JPJP-P-2022-056765 2022-03-30
PCT/JP2023/012751 WO2023190653A1 (ja) 2022-03-30 2023-03-29 医薬製剤の滅菌法と包装体

Publications (1)

Publication Number Publication Date
KR20240165977A true KR20240165977A (ko) 2024-11-25

Family

ID=88202031

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247034479A Pending KR20240165977A (ko) 2022-03-30 2023-03-29 의약 제제의 멸균법과 포장체

Country Status (8)

Country Link
US (1) US20250213588A1 (cg-RX-API-DMAC7.html)
EP (1) EP4501329A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023190653A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240165977A (cg-RX-API-DMAC7.html)
CN (1) CN118946362A (cg-RX-API-DMAC7.html)
CA (1) CA3254890A1 (cg-RX-API-DMAC7.html)
TW (1) TW202404607A (cg-RX-API-DMAC7.html)
WO (1) WO2023190653A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250214992A1 (en) * 2022-03-30 2025-07-03 Santen Pharmaceutical Co., Ltd. High-purity compound production method and purification method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0318772A (ja) 1989-06-16 1991-01-28 Mitsubishi Cable Ind Ltd 絶縁体の絶緑性能評価方法
JP2022030489A (ja) 2020-08-07 2022-02-18 株式会社ユニバーサルエンターテインメント 遊技機

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716952A (en) 1992-03-18 1998-02-10 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
US6291466B1 (en) * 1998-07-30 2001-09-18 Allergan Sales, Inc. Cholinergic agents in the treatment of presbyopia
WO2018039159A1 (en) * 2016-08-22 2018-03-01 Chase Pharmaceuticals Corporation Muscarinic m2-antagonist combination
EP4178948A2 (en) * 2020-07-29 2023-05-17 Universidade de Santiago de Compostela Functionalized isonitriles and products, preparation and uses thereof
CA3189821A1 (en) * 2020-08-04 2022-02-10 Santen Pharmaceutical Co., Ltd. Agent for treating myopia, preventing myopia and/or suppressing myopia progression
KR20230087514A (ko) * 2020-10-14 2023-06-16 산텐 세이야꾸 가부시키가이샤 안정한 의약 조성물

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0318772A (ja) 1989-06-16 1991-01-28 Mitsubishi Cable Ind Ltd 絶縁体の絶緑性能評価方法
JP2022030489A (ja) 2020-08-07 2022-02-18 株式会社ユニバーサルエンターテインメント 遊技機

Also Published As

Publication number Publication date
US20250213588A1 (en) 2025-07-03
CN118946362A (zh) 2024-11-12
JPWO2023190653A1 (cg-RX-API-DMAC7.html) 2023-10-05
CA3254890A1 (en) 2025-04-09
EP4501329A1 (en) 2025-02-05
EP4501329A4 (en) 2026-03-25
TW202404607A (zh) 2024-02-01
WO2023190653A1 (ja) 2023-10-05

Similar Documents

Publication Publication Date Title
JP6889789B2 (ja) 高眼圧症及び緑内障を治療するための方法及び組成物
KR101846804B1 (ko) 리파수딜 함유 수성 조성물을 위한 의약 제제
JP7263579B2 (ja) 眼科用医薬製品
EP3603642B1 (en) Pharmaceutical preparation
AU2016326572B2 (en) Lipoic acid choline ester compositions and methods to generate biocompatible ophthalmic formulations
JP7045359B2 (ja) 医薬製剤
JP2025129261A (ja) クロルヘキシジンを含有する医薬組成物
KR20170093839A (ko) 수성 조성물
WO2023190653A1 (ja) 医薬製剤の滅菌法と包装体
EP3590513A1 (en) Medical drug
JP2022101629A (ja) 安定な医薬組成物
JP7037349B2 (ja) 水溶性粘稠化剤を含有する医薬組成物
JP7378959B2 (ja) 眼科用組成物
EP2952190B1 (en) Stable aqueous solution
JP5753958B2 (ja) 澄明な水性液剤
WO2019189720A1 (ja) 水性液剤
EP4512404A1 (en) Composition for ophthalmic use containing sepetaprost
JP7447072B2 (ja) 水性液剤
JP2025520938A (ja) 注射用フェニレフリン組成物
JP2024090829A (ja) 滅菌容器に収容されるエピナスチン含有水性医薬組成物
WO2025079591A1 (ja) セペタプロストを含有する点眼液
JP2026027212A (ja) 水性組成物
HK40071854B (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20241016

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application